Trial of Essiac to Ascertain Its Effect in Women with Breast Cancer (TEA-BC)
The primary objective of this study was to determine the difference in health-related quality of life (HR-QOL) between women who are Essiac users and those who have never used Essiac. The researchers concluded that while Essiac does not appear to improve HR-QOL or mood states, their study did show that no women reported any negative interactions with conventional breast-cancer treatment and several women reported positive benefits including decreased side-effects during radiotherapy and chemotherapy. Researchers concluded that Essiac is safe to use in conjunction with conventional breast-cancer treatment.
Published:
The Journal of Alternative and Complementary Medicine Volume 12, Number 10, 2006, pp. 971-980 © 2006 Mary Ann Liebert, Inc.
Attribution:
Suzanna M. Zick, N.D., M.P.H.¹, Ananda Sen, Ph.D.², Yang Feng, M.P.H.ᶟ, Jen Green, N.D.⁴, Shade Olatunde, B.Sc.⁵, and Heather Boon, B.Sc. Phm., Ph.D.⁵ : ¹Integrative Medicine, University of Michigan, Ann Arbor, MI, ²Center for Statistical Consulting and Research, University of Michigan, Ann Arbor, MI ᶟDepartment of Biostatistics, University of Michigan, Ann Arbor, MI ⁴Orchard Lake, MI ⁵Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada